Clinical trials
Phase 1 Ovarian Neoplasms trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
48 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 4 |
| 2010 | 2 |
| 2012 | 1 |
| 2013 | 3 |
| 2014 | 3 |
| 2015 | 2 |
| 2017 | 3 |
| 2018 | 3 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 6 |
| 2022 | 4 |
| 2024 | 5 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 22 |
| Terminated | 11 |
| Recruiting | 9 |
| Active, not recruiting | 5 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Astellas Pharma Inc | 4 |
| AstraZeneca | 4 |
| Seagen Inc. | 3 |
| EMD Serono Research & Development Institute, Inc. | 2 |
| Imperial College London | 2 |
| Seagen, a wholly owned subsidiary of Pfizer | 2 |
| ADC Therapeutics S.A. | 1 |
| Agenus Inc. | 1 |
| Almac Discovery | 1 |
| Alterome Therapeutics, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ovarian Neoplasms | 48 |
| Carcinoma, Non-Small-Cell Lung | 20 |
| Breast Neoplasms | 14 |
| Colorectal Neoplasms | 13 |
| Stomach Neoplasms | 11 |
| Endometrial Neoplasms | 10 |
| Urinary Bladder Neoplasms | 10 |
| Triple Negative Breast Neoplasms | 9 |
| Uterine Cervical Neoplasms | 9 |
| Neoplasm Metastasis | 8 |
Trials
Showing 1 to 25 of 48. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.